10-Q Filing

ROCK CREEK PHARMACEUTICALS, INC. CIK: 776008 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-029550`
Period End Date	20150331
Filing Date	20150512
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	rcpi-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 28 Cash Flow Statement 49 Stockholders Equity 11

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	314.80M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	314.80M	shares	Point-in-time
Insurance proceeds receivable	`InsuranceProceedsReceivableCurrent`	$6.68M	USD	Point-in-time
Insurance proceeds receivable	`InsuranceProceedsReceivableCurrent`	$3.53M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.11M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$721.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$719.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.72M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.11M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$5.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.72M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$207.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$204.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$402.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$385.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
Discontinued operations assets	`DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets`	$25.00K	USD	Point-in-time
Discontinued operations assets	`DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets`	$24.00K	USD	Point-in-time
Total assets	`Assets`	$5.44M	USD	Point-in-time
Total assets	`Assets`	$8.92M	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$3.21M	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$4.36M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.51M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.93M	USD	Point-in-time
Accrued settlement	`SettlementLiabilitiesCurrent`	$6.68M	USD	Point-in-time
Accrued settlement	`SettlementLiabilitiesCurrent`	-	USD	Point-in-time
Due to stockholder	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Due to stockholder	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$535.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$533.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.40M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$350.00K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$350.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$19.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$14.80M	USD	Point-in-time
Commitments and contingencies (note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$292.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$293.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-303.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.88M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-10.84M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-9.36M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$5.44M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$8.92M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$3.35M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$473.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$693.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.82M	USD	1 Quarter
Operating loss from operations	`OperatingIncomeLoss`	$-9.69M	USD	1 Quarter
Operating loss from operations	`OperatingIncomeLoss`	$-3.82M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-9.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$3.52M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.70M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-297.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-9.70M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-297.00K	USD	1 Quarter
Loss on discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-41.00K	USD	1 Quarter
Loss on discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-135.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-338.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.83M	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.39	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.04	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Total basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.41	USD	1 Quarter
Total basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.93M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.97M	shares	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-338.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.83M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$29.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$39.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$659.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$5.23M	USD	1 Quarter
Current assets	`IncreaseDecreaseInOperatingAssets`	$-256.00K	USD	1 Quarter
Current assets	`IncreaseDecreaseInOperatingAssets`	$-3.15M	USD	1 Quarter
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$-162.00K	USD	1 Quarter
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$-5.18M	USD	1 Quarter
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.46M	USD	1 Quarter
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.68M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.00K	USD	1 Quarter
Proceeds from trademark licensing	`ProceedsFromSaleOfLicensingRights`	$9.00K	USD	1 Quarter
Proceeds from trademark licensing	`ProceedsFromSaleOfLicensingRights`	-	USD	1 Quarter
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.00K	USD	1 Quarter
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$879.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.11M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$689.00K	USD	Point-in-time
Proceeds from warrant exercise	`ProceedsFromStockOptionsExercised`	$4.17M	USD	1 Quarter
Proceeds from warrant exercise	`ProceedsFromStockOptionsExercised`	$503.00K	USD	1 Quarter
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.28M	USD	1 Quarter
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.38M	USD	1 Quarter
Cash increase (decrease) from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$-308.00K	USD	1 Quarter
Cash increase (decrease) from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$4.83M	USD	1 Quarter
Net cash flows provided by (used in) operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$4.00K	USD	1 Quarter
Net cash flows provided by (used in) operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-327.00K	USD	1 Quarter
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$4.00K	USD	1 Quarter
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-327.00K	USD	1 Quarter
Decrease (increase) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-304.00K	USD	1 Quarter
Decrease (increase) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.50M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$395.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$395.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Cash paid during the quarter for Interest	`InterestPaid`	-	USD	1 Quarter
Cash paid during the quarter for Interest	`InterestPaid`	$11.00K	USD	1 Quarter
During the three months ended March 31, 2015, the agreed upon settlement for the Securities Class Action Lawsuits were funded directly to an escrow account by insurers.	`EscrowDepositDisbursementsRelatedToPropertyAcquisition1`	$5.90M	USD	1 Quarter
During the three months ended March 31, 2015, the obligation for the Securities Class Action Lawsuits was funded directly to an escrow account by insurers.	`EscrowDepositsRelatedToPropertySales`	$5.90M	USD	1 Quarter
During the three months ended March 31, 2015, some warrants were re-priced in a private placement transaction generating a deemed dividend.	`StockIssued1`	$106.00K	USD	1 Quarter

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$-10.84M	USD	Point-in-time
Balances	`StockholdersEquity`	$-9.36M	USD	Point-in-time
Stock issuance	`StockIssuedDuringPeriodValueNewIssues`	$879.00K	USD	1 Quarter
Stock issuance (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	187,134.00	shares	Point-in-time
Warrant exercise	`WarrantAndOptionExercise`	$503.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$431.00K	USD	1 Quarter
Deemed dividend	`StockholdersEquityOther`	-	USD	1 Quarter
Net deficit	`NetIncomeLoss`	$-338.00K	USD	1 Quarter
Net deficit	`NetIncomeLoss`	$-9.83M	USD	1 Quarter
Balances	`StockholdersEquity`	$-10.84M	USD	Point-in-time
Balances	`StockholdersEquity`	$-9.36M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.